Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Ramy Farid files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- SVF Endurance (Cayman) Ltd - $17.85M of VIR open-market activity in the last 12 months
- Vicki L. Sato - $1.71M of VIR open-market activity in the last 12 months
- Backer Marianne de - $947K of VIR open-market activity in the last 12 months
- Verneuil Vanina de - $218K of VIR open-market activity in the last 12 months
- Brent Sabatini - $113K of VIR open-market activity in the last 12 months
- Jason O'Byrne - $69K of VIR open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Ramy Farid?
Ramy Farid is a corporate insider, tracked as Director of Vir Biotechnology, Inc. (VIR). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Ramy Farid last file a Form 4?
The most recent primary Form 4 on record is dated 28 May 2026, one of 4 filings going back to 2026.
Has Ramy Farid been buying or selling stock?
Recorded transactions: 0 open-market purchases and 4 open-market sales ($1.17M) across all tracked filings.
Where can I see all of Ramy Farid's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Ramy Farid and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
